CRF1 Antagonist GSK561679 in Alcoholism

NCT01187511 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

NIH

Sponsor class

Conditions

Alcohol Dependence

Interventions

DRUG: GSK561679
DRUG: Placebo

Sponsor

National Institute on Alcohol Abuse and Alcoholism (NIAAA)